nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—Mepyramine—Rosiglitazone—type 2 diabetes mellitus	0.212	0.418	CrCrCtD
Bromodiphenhydramine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.191	0.376	CrCrCtD
Bromodiphenhydramine—SLC47A1—Metformin—type 2 diabetes mellitus	0.147	0.316	CbGbCtD
Bromodiphenhydramine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.104	0.206	CrCrCtD
Bromodiphenhydramine—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0874	0.188	CbGbCtD
Bromodiphenhydramine—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0779	0.168	CbGbCtD
Bromodiphenhydramine—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0663	0.143	CbGbCtD
Bromodiphenhydramine—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0448	0.0965	CbGbCtD
Bromodiphenhydramine—SLC22A6—Losartan—type 2 diabetes mellitus	0.0409	0.0882	CbGbCtD
Bromodiphenhydramine—Captodiame—HTR2C—type 2 diabetes mellitus	0.0003	0.0712	CrCbGaD
Bromodiphenhydramine—Bedaquiline—CYP3A4—type 2 diabetes mellitus	0.000273	0.0649	CrCbGaD
Bromodiphenhydramine—Fluoxetine—HTR2C—type 2 diabetes mellitus	0.000177	0.0419	CrCbGaD
Bromodiphenhydramine—Toremifene—CYP1A2—type 2 diabetes mellitus	0.000169	0.04	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.000146	0.0346	CrCbGaD
Bromodiphenhydramine—Fluoxetine—CYP1A2—type 2 diabetes mellitus	0.000133	0.0316	CrCbGaD
Bromodiphenhydramine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	0.000126	0.0299	CrCbGaD
Bromodiphenhydramine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.000124	0.0295	CrCbGaD
Bromodiphenhydramine—Atomoxetine—HTR2C—type 2 diabetes mellitus	0.000114	0.0269	CrCbGaD
Bromodiphenhydramine—Toremifene—CYP3A4—type 2 diabetes mellitus	0.000112	0.0265	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	0.000109	0.0259	CrCbGaD
Bromodiphenhydramine—Fenoprofen—PTGS2—type 2 diabetes mellitus	0.000103	0.0245	CrCbGaD
Bromodiphenhydramine—Tamoxifen—ABCC2—type 2 diabetes mellitus	0.000101	0.024	CrCbGaD
Bromodiphenhydramine—Doxepin—ADRA2A—type 2 diabetes mellitus	9.67e-05	0.0229	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	9.65e-05	0.0229	CrCbGaD
Bromodiphenhydramine—Tolterodine—CYP3A4—type 2 diabetes mellitus	9.25e-05	0.022	CrCbGaD
Bromodiphenhydramine—Fenoprofen—ALB—type 2 diabetes mellitus	9.18e-05	0.0218	CrCbGaD
Bromodiphenhydramine—Doxepin—HTR2C—type 2 diabetes mellitus	8.9e-05	0.0211	CrCbGaD
Bromodiphenhydramine—Fluoxetine—CYP3A4—type 2 diabetes mellitus	8.83e-05	0.021	CrCbGaD
Bromodiphenhydramine—Promazine—ADRA2A—type 2 diabetes mellitus	8.59e-05	0.0204	CrCbGaD
Bromodiphenhydramine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	7.94e-05	0.0188	CrCbGaD
Bromodiphenhydramine—Promazine—HTR2C—type 2 diabetes mellitus	7.91e-05	0.0188	CrCbGaD
Bromodiphenhydramine—Fluoxetine—ALB—type 2 diabetes mellitus	7.7e-05	0.0183	CrCbGaD
Bromodiphenhydramine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	7.48e-05	0.0177	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	7.08e-05	0.0168	CrCbGaD
Bromodiphenhydramine—Imipramine—HTR2C—type 2 diabetes mellitus	6.93e-05	0.0164	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	6.92e-05	0.0164	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2C—type 2 diabetes mellitus	6.88e-05	0.0163	CrCbGaD
Bromodiphenhydramine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	6.88e-05	0.0163	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	6.88e-05	0.0163	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	6.75e-05	0.016	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	6.74e-05	0.016	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP1A2—type 2 diabetes mellitus	6.72e-05	0.0159	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.66e-05	0.00274	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	6.61e-05	0.00271	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	6.58e-05	0.0027	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.42e-05	0.00263	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.42e-05	0.00263	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.4e-05	0.00263	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	6.4e-05	0.00263	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—NFKB1—type 2 diabetes mellitus	6.36e-05	0.00261	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.36e-05	0.00261	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.3e-05	0.00259	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—MC4R—type 2 diabetes mellitus	6.22e-05	0.00255	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	6.21e-05	0.00255	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	6.04e-05	0.00248	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	6.02e-05	0.00247	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GIP—type 2 diabetes mellitus	5.99e-05	0.00246	CbGpPWpGaD
Bromodiphenhydramine—Promazine—CYP1A2—type 2 diabetes mellitus	5.97e-05	0.0142	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	5.93e-05	0.00243	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	5.9e-05	0.00242	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	5.89e-05	0.00242	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.83e-05	0.00239	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	5.78e-05	0.00237	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.74e-05	0.00235	CbGpPWpGaD
Bromodiphenhydramine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	5.72e-05	0.0136	CrCbGaD
Bromodiphenhydramine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	5.67e-05	0.0135	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	5.66e-05	0.00232	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	5.53e-05	0.00227	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP2E1—type 2 diabetes mellitus	5.49e-05	0.013	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	5.46e-05	0.013	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.45e-05	0.00224	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.45e-05	0.00224	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	5.39e-05	0.00221	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.38e-05	0.00221	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	5.37e-05	0.0022	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	5.3e-05	0.00218	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.27e-05	0.00216	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP1A2—type 2 diabetes mellitus	5.23e-05	0.0124	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	5.22e-05	0.00214	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	5.19e-05	0.0123	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	5.19e-05	0.00213	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	5.12e-05	0.0021	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	5.11e-05	0.0021	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	5.09e-05	0.00209	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.05e-05	0.00207	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	4.95e-05	0.00203	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	4.92e-05	0.00202	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	4.87e-05	0.002	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	4.84e-05	0.00199	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	4.74e-05	0.00194	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	4.64e-05	0.00191	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	4.6e-05	0.00189	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	4.58e-05	0.00188	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	4.58e-05	0.00188	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	4.5e-05	0.00185	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	4.48e-05	0.00184	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	4.46e-05	0.0106	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP3A4—type 2 diabetes mellitus	4.45e-05	0.0106	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	4.39e-05	0.0018	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.38e-05	0.0018	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	4.38e-05	0.0018	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	4.38e-05	0.0018	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	4.36e-05	0.00179	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	4.36e-05	0.00179	CbGpPWpGaD
Bromodiphenhydramine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	4.33e-05	0.0103	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	4.31e-05	0.00177	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.26e-05	0.00175	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.19e-05	0.00172	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.19e-05	0.00172	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	4.18e-05	0.00171	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.08e-05	0.00168	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.06e-05	0.00167	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	4.04e-05	0.00166	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.04e-05	0.00166	CbGpPWpGaD
Bromodiphenhydramine—Promazine—CYP3A4—type 2 diabetes mellitus	3.95e-05	0.00938	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—IAPP—type 2 diabetes mellitus	3.88e-05	0.00159	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	3.84e-05	0.00158	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	3.84e-05	0.00158	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GCGR—type 2 diabetes mellitus	3.79e-05	0.00156	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	3.77e-05	0.00155	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—AKT1—type 2 diabetes mellitus	3.69e-05	0.00151	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	3.62e-05	0.00148	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	3.61e-05	0.00148	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	3.59e-05	0.00147	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.56e-05	0.00146	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	3.51e-05	0.00144	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	3.5e-05	0.00144	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	3.49e-05	0.00143	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	3.49e-05	0.00143	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP3A4—type 2 diabetes mellitus	3.46e-05	0.00821	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	3.44e-05	0.00816	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	3.41e-05	0.0014	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.39e-05	0.00139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	3.39e-05	0.00139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	3.38e-05	0.00139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	3.37e-05	0.00138	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	3.33e-05	0.00137	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	3.32e-05	0.00136	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.3e-05	0.00135	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	3.28e-05	0.00135	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	3.28e-05	0.00135	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.25e-05	0.00134	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	3.23e-05	0.00132	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	3.19e-05	0.00131	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GIP—type 2 diabetes mellitus	3.07e-05	0.00126	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GCG—type 2 diabetes mellitus	3.04e-05	0.00125	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ALB—type 2 diabetes mellitus	3e-05	0.00712	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	2.97e-05	0.00122	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	2.88e-05	0.00118	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	2.88e-05	0.00118	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	2.82e-05	0.00116	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.81e-05	0.00115	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.79e-05	0.00115	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	2.78e-05	0.00114	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.77e-05	0.00114	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	2.68e-05	0.0011	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.67e-05	0.0011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	2.65e-05	0.00109	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	2.62e-05	0.00107	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	2.61e-05	0.00107	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	2.6e-05	0.00107	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	2.58e-05	0.00106	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	2.54e-05	0.00104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	2.52e-05	0.00104	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.5e-05	0.00103	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	2.48e-05	0.00102	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	2.46e-05	0.00101	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	2.44e-05	0.001	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	2.31e-05	0.000947	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.26e-05	0.000926	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	2.25e-05	0.000923	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	2.24e-05	0.000919	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	2.21e-05	0.000908	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	2.21e-05	0.000905	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	2.2e-05	0.000901	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	2.19e-05	0.0009	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	2.15e-05	0.000881	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	2.14e-05	0.000879	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	2.13e-05	0.000874	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.12e-05	0.000869	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.06e-05	0.000846	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.06e-05	0.000846	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	2.04e-05	0.000837	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	2.04e-05	0.000837	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	1.99e-05	0.000818	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	1.98e-05	0.000813	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	1.94e-05	0.000798	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	1.93e-05	0.000794	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	1.93e-05	0.00079	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	1.89e-05	0.000774	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	1.88e-05	0.000774	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	1.88e-05	0.00077	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	1.85e-05	0.000761	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	1.85e-05	0.00076	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	1.81e-05	0.000745	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	1.8e-05	0.000738	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	1.75e-05	0.000718	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	1.72e-05	0.000708	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	1.72e-05	0.000706	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	1.72e-05	0.000705	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	1.71e-05	0.000702	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	1.7e-05	0.000699	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	1.69e-05	0.000693	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	1.68e-05	0.000691	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	1.68e-05	0.000689	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.68e-05	0.000688	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	1.65e-05	0.000676	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	1.6e-05	0.000658	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	1.56e-05	0.00064	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	1.54e-05	0.000633	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	1.53e-05	0.000629	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.49e-05	0.000612	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	1.48e-05	0.000607	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	1.46e-05	0.000599	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	1.39e-05	0.00057	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.38e-05	0.000565	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.36e-05	0.000559	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.36e-05	0.000559	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.34e-05	0.000551	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.33e-05	0.000545	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.33e-05	0.000545	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.33e-05	0.000544	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.33e-05	0.000544	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	1.32e-05	0.000543	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.32e-05	0.000541	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.31e-05	0.000536	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.26e-05	0.000517	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.24e-05	0.000509	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.21e-05	0.000498	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.2e-05	0.000491	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.18e-05	0.000486	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.18e-05	0.000483	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.17e-05	0.00048	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.15e-05	0.000473	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.15e-05	0.000472	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.15e-05	0.000471	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.14e-05	0.000469	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.13e-05	0.000463	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.1e-05	0.000452	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.09e-05	0.000449	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.06e-05	0.000437	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.06e-05	0.000436	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.06e-05	0.000436	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.05e-05	0.000429	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.03e-05	0.000424	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.03e-05	0.000422	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.03e-05	0.000422	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.01e-05	0.000415	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.01e-05	0.000413	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.01e-05	0.000413	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.94e-06	0.000408	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.67e-06	0.000397	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.37e-06	0.000384	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.32e-06	0.000383	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.21e-06	0.000378	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	9.21e-06	0.000378	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.06e-06	0.000372	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.03e-06	0.000371	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.62e-06	0.000354	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.47e-06	0.000347	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.46e-06	0.000347	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.01e-06	0.000329	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.94e-06	0.000326	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.83e-06	0.000321	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.83e-06	0.000321	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.79e-06	0.00032	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.76e-06	0.000319	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.68e-06	0.000315	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.57e-06	0.000311	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.54e-06	0.000309	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.45e-06	0.000306	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.23e-06	0.000297	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.07e-06	0.00029	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.78e-06	0.000278	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.66e-06	0.000273	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	6.51e-06	0.000267	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.2e-06	0.000255	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.19e-06	0.000254	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.18e-06	0.000254	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.08e-06	0.000249	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.06e-06	0.000249	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.06e-06	0.000249	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.99e-06	0.000246	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.71e-06	0.000234	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.4e-06	0.000222	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	5.17e-06	0.000212	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.09e-06	0.000209	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5e-06	0.000205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5e-06	0.000205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.98e-06	0.000204	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.75e-06	0.000195	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.54e-06	0.000186	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.54e-06	0.000186	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.27e-06	0.000175	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.89e-06	0.00016	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.85e-06	0.000158	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.83e-06	0.000157	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.64e-06	0.000149	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.6e-06	0.000148	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.53e-06	0.000145	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.36e-06	0.000138	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.27e-06	0.000134	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3e-06	0.000123	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.94e-06	0.000121	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.26e-06	9.28e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.09e-06	8.56e-05	CbGpPWpGaD
